Sensorineural Hearing Loss and Systemic Autoimmune Disease: The Experience of a Systemic Immune-Mediated Diseases Unit
Open Access
- 24 March 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (3)
Abstract
Autoimmune inner ear disease (AIED) represents less than 1% of all cases of sensorineural hearing loss (SNHL) but its frequency may be underestimated due to lack of specific clinical and laboratory criteria. AIED can be associated with a systemic autoimmune disease (SAID) in 15%-30% of the cases. The objective of the present study was to characterize the clinical and prognostic factors of a cohort of patients with AIED. The authors conducted a retrospective descriptive analysis of a cohort of patients with AIED referred from the otorhinolaryngology department to a systemic immune-mediated diseases unit between March 2013 and November 2020. A consecutive sample of 39 patients with suspected AIED was referred. SNHL was defined as a fall of the hearing threshold of at least 30 decibels in three consecutive frequencies. Eight patients were excluded for not meeting the audiometric criteria or having confounding factors. The remaining 31 patients were included with a total of 50 affected ears. To classify the intensity of hearing loss, an arithmetic mean of pure tone was calculated. Normal hearing or mild hearing loss at the last pure tone audiometry of the follow-up were an indicator of good prognosis and were considered the outcome of interest. Thirty-two percent of the patients had an associated SAID. There were no differences regarding demographic and clinical characteristics when comparing patients with AIED alone and patients with AIED and a SAID, except for the positivity of antinuclear antibodies (ANA). ANA positivity was superior in patients with the association of AIED and a SAID when compared with patients with AIED alone (90% vs 50%; p=0.037). The SAID was diagnosed after the AIED in 70% of the patients, in which diagnosis of the SAID occurred a median of 4,2 (IQR 0.8-5.1) years after the diagnosis of the AIED. Normal audiometric evaluation or a mild hearing loss was achieved in 31% of the ears at the last audiometric evaluation. A normal audiometry or a mild hearing loss at the time of diagnosis was independently associated with a better outcome (31%, 14%, CI 1.71-273.69; p=0.018). Bilateral hearing loss was independently associated with a worse outcome (54%, 79%, CI 0.01-0.84; p=0.035). The use of systemic corticosteroids (p=0.941), transtympanic corticosteroids (p=0.700) and non-steroid immunomodulator drugs (p=0.986) did not affect prognosis. The presence of a SIAD did not affect the prognosis (p=0.986). In this cohort, SAID was present in one-third of the patients with AIED. A good prognosis was achieved in one-third of the patients. A normal audiometry or mild disease at presentation was associated with a good outcome, whilst bilateral involvement was associated with a bad one. Association of a SAID did not seem to influence the hearing-related prognosis. Positivity of ANA antibodies may justify performing a complementary investigation to determine the presence of a SAID.Keywords
This publication has 20 references indexed in Scilit:
- Autoimmune inner ear disease: A systematic review of managementLaryngoscope Investigative Otolaryngology, 2020
- An update on autoimmune inner ear disease: A systematic review of pharmacotherapyAmerican Journal of Otolaryngology, 2020
- Demystifying autoimmune inner ear diseaseEuropean Archives of Oto-Rhino-Laryngology, 2019
- Update on Vertigo in Autoimmune Disorders, from Diagnosis to TreatmentJournal of Immunology Research, 2018
- Autoimmune inner ear disease (AIED): A diagnostic challengeInternational Journal of Immunopathology and Pharmacology, 2018
- Can unilateral, progressive or sudden hearing loss be immune-mediated in origin?Acta Oto-Laryngologica, 2017
- Sudden Sensorioneural Hearing Loss and Autoimmune Systemic DiseasesInternational Archives of Otorhinolaryngology, 2016
- Current understanding of the pathogenesis of autoimmune inner ear disease: a reviewClinical Otolaryngology, 2015
- Autoimmune sensorineural hearing loss: the otology-rheumatology interfaceRheumatology, 2013
- Hearing Loss in Progressive Systemic Sclerosis Patients: A Comparative StudyOtolaryngology–Head and Neck Surgery, 2001